Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 152-157 , July 2006

The Role of Radiation Therapy in Locally Advanced Endometrial Cancer

  • Penny R. Anderson, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Penny R. Anderson, MD, Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111.

References 

  1. Cancer Statistics 2005 . CA Cancer J Clin . 2005;55:10–30
  2. Barnes MN , Kilgore LC . Complete surgical staging of early endometrial adenocarcinoma (Optimizing patient outcomes) . Semin Radiat Oncol . 2000;10:3–7
  3. Pustilnik T , Burke TW . Adjuvant chemotherapy for high-risk endometrial cancer . Semin Radiat Oncol . 2000;10:23–28
  4. Morrow CP , Bundy BN , Kurman RJ , et al.   Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium (A Gynecologic Oncology Group study) . Gynecol Oncol . 1991;40:55–65
  5. Grigsby EW , Perez CS , Kuske RR , et al.   Results of therapy analysis of failures and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium . Gynecol Oncol . 1987;27:44–57
  6. Wolfson A . The Role of radiotherapy for high-risk endometrial cancer . Semin Radiat Oncol . 2000;10:15–22
  7. Genest P , Drouin P , Girard A , et al.   Stage III carcinoma of the endometrium (A review of 41 cases) . Gynecol Oncol . 1987;26:77–86
  8. Creasman WT , Disaia PJ , Blessing J , et al.   Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals . Am J Obstet Gynecol . 1981;141:921–929
  9. Potish RA , Twiggs LB , Adcock LL , et al.   Role of whole abdominal radiation therapy in the management of endometrial cancer (Prognostic importance of factors indicating peritoneal metastases) . Gynecol Oncol . 1985;21:80–86
  10. Gibbons S , Martinez A , Schray M , et al.   Adjuvant whole abdominopelvic irradiation for high-risk endometrial carcinoma . Int J Radiat Oncol Biol Phys . 1991;21:1019–1025
  11. Burke TW , Gershenson DM . Chemotherpay as adjuvant and salvage treatment in women with endometrial carcinoma . Clin Obstet Gynecol . 1996;39:716–727
  12. Smith MR , Peters WA , Drescher CW , et al.   Cisplatin, doxorubicin hydrochloride and cyclophsophamide followed by radiotherapy in high-risk endometrial carcinoma . Am J Obstet Gynecol . 1994;170:1677–1681
  13. Morrow CP , Bundy BN , Homesley HD , et al.   doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II (A Gynecologic Oncology Group Study) . Gynecol Oncol . 1999;36:166–171
  14. O’Brien ME , Killackey M . Adjuvant therapy in high risk endometrial adenocarcinoma . Proc Ann Meet Am Soc Clin Oncol . 1994;13:249; (abstr)
  15. Jennings S , Dotiino P , Johnston C , et al.   Adjuvant cisplatin, doxorubicin, and etoposide and pelvic radiotherapy for advanced stage or virulent histologic subtypes of endometrial cancer . Proc Ann Meet Am Soc Clin Oncol . 1993;12:268; (abstr)
  16. Rosenberg P , Boeryd B , Simonsen E , et al.   A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer . Gynecol Oncol . 1993;48:32–37
  17. Frigero LL , Mangeli GG , Aletti GG , et al.   Concomitant radiotherapy and paclitaxel for high-risk endometrial carcinoma (Feasibility study) . Gynecol Oncol . 2000;76:249; (abstr)
  18. Greven KM , Curran WJ , Whittington R , et al.   Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications . Int J Radiot Oncol Biol Phys . 1989;17:35–39
  19. Corn BW , Lanciano RM , D’Agostino R , et al.   The relationship of local and distant failure from endometrial cancer (Defining a clinical paradigm) . Gyncol Oncol . 1997;66:411–416
  20. Greven KM , Corn B , Lanciano RM , et al.   Pathologic stage III endometrial carcinoma (Significance of extrauterine sites) . Radiat Oncol Invest . 1996;4:122–128
  21. Bruckman JE , Bloomer WD , Marck A , et al.   Stage III adenocarcinoma of the endometrium (Two prognostic groups) . Gynecol Oncol . 1980;9:12–17
  22. Connell PP , Rotmensch J , Waggoner S , et al.   The significance of adnexal involvement in endometrial carcinoma . Gynecol Oncol . 1999;74:74–79
  23. Ashman JB , Connell PP , Yamada D , et al.   Outcome of endometrial carcinoma patients with involvement of the uterine serosa . Gynecol Oncol . 2001;82:338–343
  24. Mariani A , Webb MJ , Keeney GL , et al.   Stage III endometrioid corpus cancer includes distinct groups . Gynecol Oncol . 2002;87:12–17
  25. Nelson G , Randall M , Sutton G , et al.   FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes (Analysis of treatment outcomes, prognostic variables and failure patterns following adjuvant radiation therapy) . Gynecol Oncol . 1999;75:211–214
  26. Hicks ML , Piver S , Jeffrey LP , et al.   Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus . Int J Radiat Oncol Biol Phys . 1993;26:607–611
  27. Rose PG , Cha SD , Tak WK , et al.   Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma . Int J Radiat Oncol Biol Phys . 1992;24:229–233
  28. Corn BW , Lanciano RM , Greven KM , et al.   Endometrial cancer with para-aortic adenopathy (Patterns of failure and opportunities for cure) . Int J Radiat Oncol Biol Phys . 1992;24:223–227
  29. Martinez A , Schray M , Podratz K , et al.   Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer . Int J Radiait Oncol Biol Phys . 1989;17:371–377
  30. Sutton G , Axelrod JH , Bundy BN , et al.   Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer (A Gynecologic Oncology Group study) . Gynecol Oncol . 2005;97:755–763
  31. Randall ME , Filiaci VL , Muss H , et al.   A randomized phase III trial of whole abdominal irradiation versus doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma (A Gynecologic Oncology Group study) . J Clin Oncol . 2006;24:36–44
  32. Martin JD , Gilds B , Lim P , et al.   Papillary serous carcinoma—A less radio-sensitive subtype of endometrial cancer . Gynecol Oncol . 2005;98:299–303
  33. Engleman MA , Small W . Combined modality therapy in the treatment of gynecologic malignancies . Semin Oncol . 2003;30:80–94
  34. Mundt AJ , McBride R , Rotmensch J , et al.   Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone (Implications for adjuvant radiation therapy) . Int J Radiat Oncol Biol Phys . 2001;50:1145–1153
  35. Faught W , Fung M , Krepart GV , et al.   Microscopic surgical stage IIIC endometrioid adenocarcinoma of the endometrium (Implications for bimodal adjuvant therapy) . Int J Gynecol Cancer . 1998;8:41–45
  36. Aoki Y , Kase H , Watanabe M , et al.   Stage III endometrial cancer (Analysis of prognostic factors and failure patterns after adjuvant chemotherapy) . Gynecol Oncol . 2001;83:1–5
  37. Christman JE , Kapp DS , Hendrickson MR , et al.   Therapeutic approaches to uterine papillary serous carcinoma (A preliminary report) . Gynecol Oncol . 1987;26:228–235
  38. Mallipeddi P , Kapp DS , Teng NH , et al.   Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma . Cancer . 1993;71:3076–3081
  39. Grice J , EK M , Greer B , et al.   Uterine papillary serous carcinoma (Evaluation of long-term survival in surgically stage patients) . Gynecol Oncol . 1998;69:69–73
  40. Frank AH , Tseng PC , Haffty BG , et al.   Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma . Cancer . 1991;68:1516–1519
  41. Gehrig PA , Skinner EN , Boggess JF , et al.   Sequential chemotherapy and radiotherapy in women with stage III-IV uterine serous carcinoma . 2005; (abstract 142). The Society of Gynecologic Oncologists’ 36th Annual Meeting on Women’s Cancer, Miami Beach, FL, March 19

PII: S1053-4296(06)00004-X

doi: 10.1016/j.semradonc.2006.02.003

Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 152-157 , July 2006

Article Tools